# cholestyramine powder for suspension

NDC: 67877-298
Generic name: cholestyramine powder for suspension
Labeler / Manufacturer: Ascend Laboratories, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: POWDER, FOR SUSPENSION
Routes: ORAL
Marketing started: 20211020

FDA application: ANDA211856

## Active ingredients

- CHOLESTYRAMINE: 4 g/8.78g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"67877-298"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=67877-298
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=430ac07e-8524-4dec-a599-b7ebc56d9563